⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001991806

Ketchum John B

Reports to the SEC for 1 company · BOSTON, MA

Transactions

8

Companies

1

Filings

4

CIK

0001991806

Forms 4 and 5

Insider transactions

8 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-05	TNGXTango Therapeutics, Inc.A Award	Director	AAward	+4,000 sh	—	—	24,937
2026-06-05	TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2025-06-05	TNGXTango Therapeutics, Inc.A Award	Director	AAward	+6,250 sh	—	—	20,937
2025-06-05	TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+37.5K sh	—	—	37,500
2024-06-05	TNGXTango Therapeutics, Inc.A Award	Director	AAward	+4,687 sh	—	—	14,687
2024-06-05	TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+28.1K sh	—	—	28,125
2023-08-29	TNGXTango Therapeutics, Inc.A Award	Director	AAward	+10K sh	—	—	10,000
2023-08-29	TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+60K sh	—	—	60,000

Recent filings

4

Accepted (ET)
Jun 84
Ketchum John B0001193125-26-262227
SEC(opens sec.gov)
Jun 94
Ketchum John B0000950170-25-083906
SEC(opens sec.gov)
Jun 74
Ketchum John B0000950170-24-070860
SEC(opens sec.gov)
Aug 314
Ketchum John B0000950170-23-045783
SEC(opens sec.gov)

Companies

1

Tango Therapeutics, Inc.DirectorTNGX

Address

C/O TANGO THERAPEUTICS, INC., 201 BROOKLINE AVE., SUITE 901

BOSTON, MA, 02215